within Pharmacolibrary.Drugs.ATC.G;

model G03AA04
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.5,
    Cl             = 3.3333333333333333e-06,
    adminDuration  = 600,
    adminMass      = 1 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.005,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0008333333333333334,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>G03AA04</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Combination of megestrol, a synthetic progestogen, and ethinylestradiol, a synthetic estrogen. This combination has been used as an oral contraceptive for the prevention of pregnancy. It is not widely used today and is no longer a commonly approved formulation.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters for the fixed-dose combination of megestrol and ethinylestradiol in healthy adult women. No specific published sources report joint PK parameters for both drugs in this combination.</p><h4>References</h4><ol><li><p>Adlercreutz, H, et al., &amp; Fotsis, T (1979). Steroid absorption and enterohepatic recycling. <i>Contraception</i> 20(3) 201–223. DOI:<a href=\"https://doi.org/10.1016/0010-7824(79)90094-5\">10.1016/0010-7824(79)90094-5</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/389544/\">https://pubmed.ncbi.nlm.nih.gov/389544</a></p></li><li><p>Mueck, AO, &amp; Sitruk-Ware, R (2011). Nomegestrol acetate, a novel progestogen for oral contraception. <i>Steroids</i> 76(6) 531–539. DOI:<a href=\"https://doi.org/10.1016/j.steroids.2011.02.002\">10.1016/j.steroids.2011.02.002</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/21335021/\">https://pubmed.ncbi.nlm.nih.gov/21335021</a></p></li><li><p>Goldzieher, JW, et al., &amp; Kraemer, DC (1978). Comparative studies of the ethynyl estrogens used in oral contraceptives: effects with and without progestational agents on plasma androstenedione, testosterone, and testosterone binding in humans, baboons, and beagles. <i>Fertility and sterility</i> 29(4) 388–396. DOI:<a href=\"https://doi.org/10.1016/s0015-0282(16)43211-5\">10.1016/s0015-0282(16)43211-5</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/417948/\">https://pubmed.ncbi.nlm.nih.gov/417948</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end G03AA04;
